High-throughput screening (HTS) generates an abundance of data that are a valuable resource to be mined. Dockers and data miners can use "real-world" HTS data to test and further develop their tools. A screen of 50,000 diverse small molecules was carried out against Escherichia coli dihydrofolate reductase (DHFR) and compared with a previous screen of 50,000 compounds against the same target. Identical assays and conditions were maintained for both studies. Prior to the completion of the second screen, the original screening data were publicly released for use as a "training set," and computational chemists and data analysts were challenged to predict the activity of compounds in this second "test set." Upon completion, the primary screen of the test set generated no potent inhibitors of DHFR activity. (Journal of Biomolecular Screening 2005:653-657) 
INTRODUCTION
B ACTERIA REQUIRE TETRAHYDROFOLATE (H 4 -folate) for the synthesis of formyl-methionyl tRNA fMet , which is essential for the initiation of protein synthesis. The final step in the biosynthesis of H 4 -folate in most bacteria and eukaryotes is the reduction of dihydrofolate by the enzyme dihydrofolate reductase (DHFR). Thus, DHFR has been well characterized and is the target for a number of drugs, including trimethoprim and methotrexate in bacteria and eukaryotes, respectively. Escherichia coli DHFR has been screened in a high-throughput manner against a library of 50,000 diverse, high-quality compounds sourced from Maybridge plc. 1 The McMaster High-Throughput Screening (HTS) Lab, where this work was carried out, announced a data-mining competition and made the primary results of this HTS campaign, as well as individual compound structures, public (http://hts.mcmaster.ca/ HTSDataMiningCompetition.htm) to be used as a "training set" for computational chemists and data analysts. A second set of 50,000 compounds was designated as a "test library," and these structures were also publicized. Participants were asked to predict and rank-order actives from this collection. The test library was from ChemBridge Corporation and also consisted of diverse molecules. Both libraries were screened in duplicate with the same assay reagents and conditions. This second study provided data from which a direct comparison could be made between virtual and wet screening as is discussed throughout this issue. Herein, the results of the screening campaign are outlined and compared with the initial training set data.
MATERIALS AND METHODS

Materials
Nunc 96-well clear flat-bottom polystyrene plates (Nalge Nunc, Rochester, NY) were used for all assays. E. coli DHFR was cloned 1 and purified 2 as described previously. Dihydrofolic acid (DHF) and nicotinamide adenine dinucleotide phosphate (NADPH) were purchased from Sigma-Aldrich.
DHFR activity assay
Assay reactions, with a final reaction volume of 200 µL, consisted of 40 µM NADPH, 30 µM DHF, 5 nM DHFR, 50 mM Tris (pH 7.5), 0.01% (v/v) Triton X-100, and 10 mM βmercaptoethanol (BME), unless otherwise noted. DHFR activity at room temperature was determined by continuous monitoring of the decrease of NADPH as measured by absorbance at 340 nm. Note that the K m for DHF is 9.5 µM. 1 Typically, screens are run at a substrate concentration equal to K m or lower, if favoring competitive inhibitors; 3 however, due to signal sensitivity in this assay, the screen was carried out at 30 µM DHF, identical to the previous screen of the training set, which yielded competitive inhibitors.
Primary screening
The SAGIAN Core System (Beckman Coulter, Inc., Fullerton, CA) used for this screen was integrated through SAMI and equipped with an ORCA arm for labware transportation, a 96channel head Biomek FX with stacker carousel, a tipbox storage and delidding station, a SpectraMax Plus 384 (Molecular Devices, Sunnyvale, CA) plate reader, and an ambient temperature labware storage carousel. DHFR activity assays contained reagents as described, as well as 1 of the following: (1) ChemBridge compounds in DMSO (at a final concentration of 10 µM), (2) 1.5 µM trimethoprim as a low-activity control, (3) 12 nM trimethoprim as a reference control to reflect half the maximal DHFR activity, or (4) neat DMSO for high-activity controls. All reactions were done in duplicate and had a final DMSO concentration of 1% (v/v). Primary hits were defined as those compounds that reduced DHFR activity to 75% of the average residual activity of the high (uninhibited) controls. ActivityBase (version 5.0.5, IDBS Ltd., Emeryville, CA) and Spotfire DecisionSite (version 7.1.1, Spotfire, Inc., Somerville, MA) were used for data analysis.
Secondary screening
Dose-response curves of the hits from the primary screen were determined by DHFR activity assays, as described above, in the presence of 7 compound concentrations (0.05-50 µM). Data were fit to the following 4-parameter equation, with background correction: [ ] IC (1) using GraFit (version 4.0.10, Erithacus Software Ltd., Surrey, UK), where v is the reaction rate, a is the calculated reaction rate in the absence of inhibitor, I is the concentration of inhibitor, s is the slope factor, and c is the calculated background. Additional doseresponse curves were constructed for 20 reordered compounds in the presence of 0.2 to 200 µM inhibitor. This was done at 2 DHF concentrations (30 and 100 µM) to examine competition with this substrate. A subset of these 20 molecules was tested in the presence and absence of 0.1 mg/mL bovine serum albumin (BSA) to detect nonspecific inhibition. ChemBridge generously provided a total of 105 analog molecules of the 20 reordered compounds, and these were screened at 10 µM as described above. Also, compounds predicted by participants in the competition as false negatives were retested at several concentrations to verify their activity against DHFR.
RESULTS AND DISCUSSION
Primary library screen
In screening the test set compounds, the enzyme and substrate concentrations, buffer conditions, and additional reagents (BME, Triton) used were identical to those in the screen of the original training set. Therefore, direct comparisons between the data of the training and test sets are justified. Validation of the appropriateness of these comparisons is also illustrated by the quality of both screening campaigns, as reflected by the statistical parameter Z′, 4 which is dependent on the controls of the screen. The calculated Z′ values of the training and test screens were 0.73 and 0.72, respectively, demonstrating the equivalence in quality of the 2 screens. This is not surprising because the same assay was used in both campaigns. Statistically, the results of the 2 screens are comparable, as outlined in Table 1 . The hit threshold of the training screen was determined to be 75% residual enzyme activity and yielded 32 primary hits (not 62 as previously reported by Zolli-Juran et al. 1 ), with DHFR activities ranging from approximately 2% to 75% in both replicates. Using the same cutoff of 75% residual enzyme activity for comparison purposes between the 2 screens, 42 compounds were identified from the test collection as primary hits. A plot of the duplicate data set from the primary screen of E. coli DHFR against 50,000 test compounds is shown in Figure 1 . From an initial inspection of this replicate plot, it is evident that none of the tested compounds were potent inhibitors of DHFR. Although more hits were found in this library, these compounds appeared to be weaker inhibitors than the hits in the training set, as they resulted in higher residual activities, ranging from 50% to 75% ( Table 1) . The lower average activity together with the higher standard deviation of hits from the training library indicated that these molecules were generally more active against DHFR and had a greater range in potency. As both screening campaigns were run with a final compound concentration of 10 µM, the training library yielded more potent hits against DHFR. An examination of the data distribution of the 2 screens, shown in Figure 2 , provides further insight into the activity of the compounds in each collection. Here, the duplicate determinations of residual activities obtained for every compound were averaged and subsequently categorized based on a range of residual activities. This clearly illustrates that potent inhibitors were found in the training library (0%-50% activity range), whereas no compounds from the test set fell into this range. Interestingly, this compound collection appeared to contain more activators of DHFR where many compounds showed stimulation to more than 175% residual activity. In this work, we have not explored the nature of these activators but note that the distribution of activators and inhibitors depicted in Figure 2 is likely not the result of a shift in the data distribution between the 2 screens. High controls and IC 50 determinations for trimethoprim demonstrated unchanged enzyme kinetic parameters for the screens of the training and test sets. It is important to note that the 2 libraries screened contain diverse molecules with little overlap in chemical space between the collections, as discussed elsewhere in this issue (see Bender et al. 5 ). Therefore, although it is unfortunate that potent hits were not found in the test library, this result is not unheard of in the field of screening, given that approximately 10 60 drug-like molecules occupy chemical space 6 and that 50,000 molecules were screened.
Hit follow-up
As illustrated in Figure 1 , the edge of the hit zone is noisy with data. Therefore, in the spirit of the McMaster HTS Data Mining and Docking Competition, it was elected to venture into this noise and examine the 96 most active compounds against DHFR. This corresponded to an upper limit of 79% residual activity. The doseresponse relationships for the selected compounds from the test library were evaluated. The data obtained gave plots that fell into 3 categories, as illustrated in Figure 3 . Most compounds (58) showed no dose response up to 50 µM, whereas the rest of the molecules showed moderate inhibition. The large number of compounds showing no dose response in this study is not surprising given that they displayed weak inhibition in the screen and fell around the noisy border of the hit zone ( Fig. 1 ). Of the remaining 38 compounds examined, 15 compounds showed some dose response but precipitated at the highest concentrations tested (Fig.  3B) . The rest of the hits showed dose response; however, complete inhibition of DHFR was not achieved by any of these, as illustrated in Figure 3C , and the IC 50 values determined were extrapolations, most with considerable errors (data not shown). The highest concentration of library stock available in-house was used for these dose-response studies and was insufficient to obtain a full inhibition profile; therefore, additional compound was acquired.
Twenty compounds were reordered in quantity, and doseresponse studies were subsequently run over a greater inhibitor concentration range and at 2 different concentrations of DHF. Unfortunately, the errors associated with the data were large, primarily due to the insolubility of the compounds in the reaction buffer at high concentrations. One would expect an increase in the IC 50 value with an increase in DHF concentration for compounds that behave as competitive inhibitors. However, due to precipitation of the compounds at the higher concentrations tested, reliable data could not be obtained for these competition experiments. Thus, it was not possible to conclude whether any of the molecules exhibited a response that would have suggested a competitive mode of inhibition, as was seen with the model inhibitor trimethoprim (data not shown).
In a final attempt to provide data for the participants in the competition who may have predicted compounds of low potency, the dose response of a subset of the 20 compounds was retested, and their specificity toward DHFR was evaluated. Promiscuous inhibitors can be identified by a loss of inhibitory activity in the presence of detergent. The screening assay contained 0.01% (v/v) Triton X-100; however, the effect of detergent on nonspecific inhibitors de- pends on several factors, including the type of detergent used, its concentration, and the compound itself. 7 Another indicator of nonspecific binding is decreased inhibition in the presence of BSA, as excess protein would attenuate nonspecific inhibitors, which likely behave as aggregates. 8 The presence of 0.1 mg/mL BSA in the assay did not interfere with DHFR activity and, as expected, had no effect on the IC 50 of trimethoprim, as illustrated in Figure 4 . However, the compounds that were retested displayed no dose response again; thus, no change in inhibition could be determined between the data in the presence and absence of BSA. Thus, further examination of the activity of hits that clustered around the cutoff threshold in the primary screen showed that these were not true inhibitors of DHFR. Small molecules that are more potent modulators of a target may be found in chemical analogs of hit compounds. To this end, ChemBridge Corp. provided a hit follow-up service that supplied 105 molecules based around the structures of the 20 compounds tested for competitive behavior with respect to DHF. These compounds were tested with DHFR at 10 µM under the standard assay conditions. Two of these molecules showed some inhibition (67% and 73% residual DHFR activity) but did not reconfirm in an IC 50 analysis. The inhibition observed by these molecules fell just outside of the standard error of the data for this screen, as was seen with the original hits in the primary campaign. Thus, of the 50,000 test compounds screened and the additional 105 molecules analogous to 20 of the most potent of these, no inhibitors of DHFR activity were found.
A number of participants in the McMaster HTS Data Mining and Docking Competition made predictions of compounds that would register as false negatives in the screen. A total of 20 molecules were retested at the screening concentration (10 µM), as well as at several higher concentrations up to 75 µM. None of the predicted molecules acted as inhibitors at the screening concentration and are therefore not true false negatives. Two molecules, described elsewhere in this issue (Brenk et al. 9 ), displayed weak inhibition at concentrations higher than that used in the primary screen. This finding illustrates the purpose of choosing a relatively low compound concentration for screening: the campaign was intended to focus on reasonably potent inhibitors of DHFR, preferably in the sub-micromolar range. Screening at a higher compound concentration would have most likely resulted in more hits, although these would have had a significantly reduced effect on DHFR. Thus, even though potent hits were not found among the test molecules screened, the high Z′ value achieved illustrates the robustness of the assay with respect to HTS and is also supported by good data reproducibility, as shown in Figure 1 .
CONCLUSIONS
HTS is a multistage analytical process directed toward accelerated identification of lead molecules that modulate a given target. The success of such a campaign is highly dependent on the robustness and sensitivity of the assay as well as the size and diversity of the compound collection tested. With this latter point in mind, it is not unheard of that some screening campaigns may not generate leads. The screen of the 50,000 training molecules yielded 12 potent hits, the majority of which were novel DHFR inhibitors that fell into 3 broad structural classes. In contrast, hit compounds from the structurally different 50,000 test collection screened were far less potent inhibitors of DHFR activity. This study illustrates that there is a somewhat serendipitous aspect to HTS in the selection of an appropriate compound collection for screening. As several inhibitors of DHFR were pulled from the initial 50,000 molecule screen, it was anticipated that a screen of another 50,000 molecules would also yield inhibitors. However, considering the vastness of chemical space, that not 1 of 50,000 compounds tested significantly inhibited DHFR activity is well within the realm of possibility for HTS.
SUPPLEMENTARY INFORMATION
The full data set for this screen, including structures of the 50,000 compounds screened and the analogs of reordered hits, is available for download at http://hts.mcmaster.ca/Competition_1 .html.
